Stay informed with the latest litigation news. Explore now

IP Verse

Alfred E Tiefenbacher competitive analysis

Latest publications and patents of Alfred E Tiefenbacher New

Explore the latest publications and patents granted to Alfred E Tiefenbacher, showcasing their recent innovations and technological advancements.

Last updated on: Sep 9, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Alfred E Tiefenbacher

EP3785702
Jul 20, 2022Microparticulate Varenicline CitrateRevoked
EP3409272
Jun 24, 2020Pharmaceutical Composition Comprising Eltrombopag Olamine, Reducing Sugar, And Polymeric BinderRevoked
EP3395331
Aug 21, 2019Pharmaceutical Tablet Composition Comprising Eltrombopag OlamineRevoked

Latest oppositions filed by Alfred E Tiefenbacher

Explore patent oppositions filed by Alfred E Tiefenbacher against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
EP4084779
Compositions Of 1-(4-Bromo-5-(1-Ethyl-7-(Methylamino)-2-Oxo-1,2-Dihydro-1,6-Naphthyridin-3-Yl)-2-Fluorophenyl)-3-PhenylureaDECIPHERA PHARMACEUTICALSMay 28, 2025
EP3478286
Methods Of Treating Ovarian CancerTESAROOct 2, 2024
EP4084778
Amorphous Kinase Inhibitor Formulations And Methods Of Use ThereofDECIPHERA PHARMACEUTICALSAug 1, 2024
EP3626270
New UseNOVARTISJun 25, 2024
EP3996688
Pharmaceutical PreparationMERCK PATENTJun 5, 2024
EP3345604
Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsH LUNDBECKMar 1, 2024
EP3294283
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISDec 7, 2023
EP3000467
Treatment Regimen Utilizing Neratinib For Breast CancerWYETHNov 28, 2023
EP3191461
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022

Latest patents of Alfred E Tiefenbacher opposed by its competitors

Explore Alfred E Tiefenbacher's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3785702
Jul 20, 2022Microparticulate Varenicline Citrate1
EP3409272
Jun 24, 2020Pharmaceutical Composition Comprising Eltrombopag Olamine, Reducing Sugar, And Polymeric Binder1
EP3395331
Aug 21, 2019Pharmaceutical Tablet Composition Comprising Eltrombopag Olamine1

Latest PTAB cases involving Alfred E Tiefenbacher New

Discover the latest PTAB cases involving Alfred E Tiefenbacher, highlighting their recent legal challenges and patent disputes.